Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002019422 | SCV002284465 | uncertain significance | Intellectual disability, autosomal dominant 1 | 2023-10-13 | criteria provided, single submitter | clinical testing | This sequence change replaces arginine, which is basic and polar, with threonine, which is neutral and polar, at codon 491 of the MBD5 protein (p.Arg491Thr). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with MBD5-related conditions. ClinVar contains an entry for this variant (Variation ID: 1497390). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt MBD5 protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Mendelics | RCV002246647 | SCV002518220 | uncertain significance | not specified | 2022-05-04 | criteria provided, single submitter | clinical testing | |
Laboratorio de Genetica e Diagnostico Molecular, |
RCV002252748 | SCV002523730 | likely benign | See cases | 2020-07-01 | criteria provided, single submitter | clinical testing | ACMG classification criteria: PM2, BP1, BP4 |
Ce |
RCV003434381 | SCV004154070 | uncertain significance | not provided | 2022-06-01 | criteria provided, single submitter | clinical testing | MBD5: PM2 |